Showing results 1 to 20 of 85
next >
Issue Date | Title | Author(s) |
2015 | Acquired Resistance Mechanisms in Small Cell Lung Cancer Mediated by the Cancer Stem Cell Marker Calcium Channel alpha 2 delta 1 Subunit | Wang, Jie; Yu, Jiangyong; Tian, Yanhua; Bai, Hua; Wang, Zhijie; Yu, Sifan |
2015 | Activation of the BMP-BMPR pathway conferred resistance to EGFR-TKIs in lung squamous cell carcinoma patients with EGFR mutations | Wang, Zhijie; Shen, Zhirong; Li, Zhenxiang; Duan, Jianchun; Fu, Shuai; Liu, Zhentao; Bai, Hua; Zhang, Zemin; Zhao, Jun; Wang, Xiaodong; Wang, Jie |
2015 | Activation of the BMP-BMPR pathway conferred resistance to EGFR-TKIs in lung squamous cell carcinomas patients with EGFR mutations. | Wang, Jie; Wang, Zhijie; Li, Zhenxiang; Shen, Zhirong; Fu, Shuai; Liu, Zhentao; Cheng, Liang; Bai, Hua; Duan, Jianchun; Zhao, Jun; Wang, Shuhang; Zhuo, Minglei |
2015 | Activation of the BMP-BMPR pathway conferred resistance to EGFR-TKIs in lung squamous cell carcinomas patients with EGFR mutations. | Wang, Jie; Wang, Zhijie; Li, Zhenxiang; Shen, Zhirong; Fu, Shuai; Liu, Zhentao; Cheng, Liang; Bai, Hua; Duan, Jianchun; Zhao, Jun; Wang, Shuhang; Zhuo, Minglei |
Apr-2020 | Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L)1 Inhibitors | Wang, Zhijie; Duan, Jianchun; Wang, Guoqiang; Zhao, Jing; Xu, Jiachen; Han, Jiefei; Zhao, Zhengyi; Zhao, Jun; Zhu, Bo; Zhuo, Minglei; Sun, Jianguo; Bai, Hua; Wan, Rui; Wang, Xin; Fei, Kailun; Wang, Shuhang; Zhao, Xiaochen; Zhang, Yuzi; Huang, Mengli; Huang, Depei; Qi, Chuang; Gao, Chan; Bai, Yuezong; Dong, Hua; Xiong, Lei; Tian, Yanhua; Wang, Di; Xu, Chunwei; Wang, Wenxian; Li, Junling; Hu, Xingsheng; Cai, Shangli; Wang, Jie |
2013 | Alterations in EGFR and Related Genes following Neo-Adjuvant Chemotherapy in Chinese Patients with Non-Small Cell Lung Cancer | Wang, Shuhang; An, Tongtong; Duan, Jianchun; Zhang, Lijian; Wu, Meina; Zhou, Qinghua; Chen, Jinfeng; Zhuo, Minglei; Yang, Lu; Wang, Yuyan; Bai, Hua; Wang, Jie |
2014 | Analysis of BIM (BCL-2 like 11 gene) deletion polymorphism in Chinese non-small cell lung cancer patients | Zhong, Jia; Li, Zheng-Xiang; Zhao, Jun; Duan, Jian-Chun; Bai, Hua; An, Tong-Tong; Yang, Xiao-Dan; Wang, Jie |
2013 | ANALYSIS OF BIM DELETION POLYMORPHISM IN CHINESE PATIENTS WITH NSCLC | Zhong, Jia; Wang, Jie; Li, Zhenxiang; Yang, Xiaodan; Bai, Hua; Duan, Jianchun |
2013 | ANALYSIS OF SENSITIVITY OF LUNG SQUAMOUS CARCINOMA WITH EGFR MUTATION TO EGFR-TKIS AND RESISTANT MECHANISM | Wang, Zhijie; Li, Zhenxiang; Yang, Xiaodan; Bai, Hua; Zhuo, Minglei; Duan, Jianchun; Wang, Jie |
2018 | Analysis of topoisomerase I expression and identification of predictive markers for efficacy of topotecan chemotherapy in small cell lung cancer | Lv, Chunxin; Liu, Xiuju; Zheng, Qiwen; Chen, Hanxiao; Yang, Xue; Zhong, Jia; Wang, Yuyan; Duan, Jianchun; Wang, Zhijie; Bai, Hua; Wu, Meina; Zhao, Jun; Wang, Jie; Wang, Ziping; An, Tongtong; Zhuo, Minglei |
2019 | Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel | Wang, Zhijie; Duan, Jianchun; Cai, Shangli; Han, Miao; Dong, Hua; Zhao, Jun; Zhu, Bo; Wang, Shuhang; Zhuo, Minglei; Sun, Jianguo; Wang, Qiming; Bai, Hua; Han, Jiefei; Tian, Yanhua; Lu, Jing; Xu, Tongfu; Zhao, Xiaochen; Wang, Guoqiang; Cao, Xinkai; Li, Fugen; Wang, Dalei; Chen, Yuejun; Bai, Yuezong; Zhao, Jing; Zhao, Zhengyi; Zhang, Yuzi; Xiong, Lei; He, Jie; Gao, Shugeng; Wang, Jie |
2015 | Assessment of PD-L1, TGF-beta Expression and Tumor-Infiltrating CD8+T Cells in Advanced Thymic Epithelial Tumors | Wang, Jie; Chen, Han; Bai, Hua; Zhao, Jun; Wang, Shuhang |
Feb-2022 | Biomarker subset analysis of a phase IIIb, open-label study of afatinib in EGFR tyrosine kinase inhibitor-naive patients with EGFRm plus non-small-cell lung cancer | Zhao, Jun; Bai, Hua; Wang, Xin; Wang, Yuyan; Duan, Jianchun; Chen, Hanxiao; Xue, Zhiyi; Tian, Yahui; Cseh, Agnieszka; Huang, Dennis Chin-Lun; Wu, Yi-Long; Wang, Jie |
2013 | Clinical features of patients with lung adenocarcinomas harboring BRAF V600E mutations | An, Tongtong; Wang, Jie; Bai, Hua; Wang, Zhijie; Zhao, Jun; Duan, Jianchun; Zhuo, Minglei; Wu, Meina; Wang, Yuyan; Wang, Shuhang |
2016 | Clinical outcome of epidermal growth factor receptor-tyrosine kinase inhibitors therapy for patients with overlapping kirsten rat sarcoma 2 viral oncogene homolog and epidermal growth factor receptor gene mutations | Zhang, Hong; Bai, Hua; Yang, Xiaodan; Zhong, Jia; An, Tongtong; Zhao, Jun; Wang, Jie |
2016 | Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21 | Yu, Jiang-Yong; Yu, Si-Fan; Wang, Shu-Hang; Bai, Hua; Zhao, Jun; An, Tong-Tong; Duan, Jian-Chun; Wang, Jie |
Mar-2021 | Comparative study of EGFR mutations detected in malignant pleural effusion, plasma and tumor tissue in patients with adenocarcinoma of the lung (vol 135, pg 116, 2019) | Wang, Shuhang; Chen, Hanxiao; Zhong, Jia; Qin, Haifeng; Bai, Hua; Zhao, Jun; Wang, Jie |
2012 | Comparison of different methods for detecting epidermal growth factor receptor mutations in peripheral blood and tumor tissue of non-small cell lung cancer as a predictor of response to gefitinib | Xu, Fei; Wu, Jingxun; Xue, Cong; Zhao, Yuanyuan; Jiang, Wei; Lin, Liping; Wu, Xuan; Lu, Yachao; Bai, Hua; Xu, Jiasen; Zhu, Guanshan; Zhang, Li |
2017 | Comprehensive Analysis of the Discordance of EGFR Mutation Status between Tumor Tissues and Matched Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer | Wan, Rui; Wang, Zhijie; Lee, J. Jack; Wang, Shuhang; Li, Qingqing; Tang, Fuchou; Wang, Jin; Sun, Yu; Bai, Hua; Wang, Di; Zhao, Jun; Duan, Jianchun; Zhuo, Minglei; An, Tongtong; Wu, Meina; Chen, Zhaoli; Yang, Zhenlin; Wang, Jie |
20-May-2021 | Construction and validation of an eight-gene risk prediction model for stage II-IIIA lung adenocarcinoma. | Duan, Jianchun; Bai, Hua; Sun, Yiting; Gai, Fei; Tian, Shenya; Xu, Wenfang |